Michael Dougan - Concepedia

Author

Michael Dougan

Also Known As

Dougan, Michael, M. Dougan, MICHAEL L. DOUGAN, Michael Dougan, Michael L Dougan, Michael L. Dougan, Michael Lawrence Dougan, Susan Davidson

328

Publications

13K

Citations

H-Index

109

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital Massachusetts Institute of Technology

About

Michael Dougan is an author at Massachusetts General Hospital specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	30	4.1K
2	Health Sciences	2	2	67
3	Engineering	1	1	52
4	Law	1	1	23
5	Natural Sciences	1	1	52

Michael Dougan

Publications

9.4K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd, New England Journal of Medicine	2020	1.4K
SARS-CoV-2 viral load is associated with increased disease severity and mortality Jesse Fajnzylber, James Regan, Kendyll Coxen, Nature Communications Plasma ViremiaSars-cov-2 Viral LoadViral PersistenceViral DiagnosticsCovid-19 Pandemic	2020	957
De novo design of potent and selective mimics of IL-2 and IL-15 Daniel‐Adriano Silva, Shawn Yu, Umut Y. Ulge, Nature CytokineMedicineSelective MimicsImmunologyImmunologic Mechanism	2019	524
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy Adrienne Luoma, Shengbao Suo, Hannah L. Williams, Cell InflammationCancer ImmunosurveillanceMucosal ImmunologyColon Inflammation InducedImmunology	2020	446
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy Jordan A. Krall, Ferenc Reinhardt, Oblaise Mercury, Science Translational Medicine	2018	416
Durable antitumor responses to CD47 blockade require adaptive immune stimulation Jonathan T. Sockolosky, Michael Dougan, Jessica R. Ingram, Proceedings of the National Academy of Sciences	2016	343
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice Yushu Joy Xie, Michael Dougan, Noor Jailkhani, Proceedings of the National Academy of Sciences	2019	299
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells Mohammad Rashidian, Jessica R. Ingram, Michael Dougan, The Journal of Experimental Medicine	2017	244
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review Michael Dougan, Yinghong Wang, Alberto Rubio‐Tapia, Gastroenterology Viral HepatitisImmunologyGastroenterologyHepatitisExpert Review	2020	241
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors Amanda C. Guidon, Leeann B Burton, Bart K. Chwalisz, Journal for ImmunoTherapy of Cancer ImmunodeficienciesImmunologyPathologyConsensus Disease DefinitionsImmunotherapy	2021	197

Page 1